Anixa Biosciences Inc. (NASDAQ: ANIX)
$3.22
+0.4500 ( +16.25% ) 235.7K
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
Market Data
Open
$3.22
Previous close
$2.77
Volume
235.7K
Market cap
$103.06M
Day range
$2.71 - $3.29
52 week range
$2.15 - $5.13
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 18, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 10, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
4 | Insider transactions | 1 | Jun 07, 2024 |
10-q | Quarterly Reports | 65 | Jun 04, 2024 |
8-k | 8K-related | 15 | May 08, 2024 |
4 | Insider transactions | 1 | May 02, 2024 |
4 | Insider transactions | 1 | Apr 10, 2024 |